Bell's palsy, a nerve condition that causes sudden facial paralysis on one side, affecting up to 30,000 Americans yearly.

There is no standard course of treatment for Bell’s palsy ... steroids to reduce inflammation and swelling around the facial ...

The ISEV presentation will feature facial nerve regeneration, marking the Company’s third therapeutic indication, alongside its ongoing programs in spinal cord injury and optic nerve regeneration.

These anatomical corridors are critical in avoiding nerve injury and ... technique's versatility across diverse facial anatomies and aging patterns. Surgeons attending the course also benefited ...

NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its ... such as the treatment of epilepsy. Expanding into facial pain broadens the clinical impact of our technology ...

submission to the U.S. Food and Drug Administration for its OneRF Trigeminal Nerve Ablation System, a device intended to treat trigeminal neuralgia, a severe and chronic facial pain disorder.

Prof. Shulamit Levenberg, PhD, Co-Founder of NurExone, Director of the Technion Center for 3D Bioprinting added “I’m thrilled to see yet another indication, facial nerve regeneration ...

Partially sponsored by NurExone, the preclinical study was conducted independently in an academic setting and offered potential confirmation of PTEN downregulation as a strategy to promote axon ...